Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.

Ruiz C, Martins JR, Rudin F, Schneider S, Dietsche T, Fischer CA, Tornillo L, Terracciano LM, Schreiber R, Bubendorf L, Kunzelmann K.

PLoS One. 2012;7(8):e43265. doi: 10.1371/journal.pone.0043265. Epub 2012 Aug 17.

PMID:
22912841
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.

Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robé A, Roux M, Abecassis J, de Reyniès A, Wasylyk B.

Br J Cancer. 2010 Aug 24;103(5):715-26. doi: 10.1038/sj.bjc.6605823. Epub 2010 Jul 27.

PMID:
20664600
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E1026-34. doi: 10.1073/pnas.1217072110. Epub 2013 Feb 19.

PMID:
23431153
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma.

van de Schootbrugge C, Bussink J, Span PN, Sweep FC, Grénman R, Stegeman H, Pruijn GJ, Kaanders JH, Boelens WC.

BMC Cancer. 2013 Mar 18;13:128. doi: 10.1186/1471-2407-13-128.

PMID:
23506259
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas.

Bernaldo de Quirós S, Merlo A, Secades P, Zambrano I, de Santa María IS, Ugidos N, Jantus-Lewintre E, Sirera R, Suarez C, Chiara MD.

BMC Cancer. 2013 Mar 14;13:116. doi: 10.1186/1471-2407-13-116.

PMID:
23497198
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, Sun D.

Mol Pharm. 2010 Aug 2;7(4):1283-90. doi: 10.1021/mp100073s.

PMID:
20540527
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.

Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, Raben D, Weed SA.

Cancer Res. 2006 Aug 15;66(16):8017-25.

PMID:
16912177
[PubMed - indexed for MEDLINE]
Free Article
8.

Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.

Tan KD, Zhu Y, Tan HK, Rajasegaran V, Aggarwal A, Wu J, Wu HY, Hwang J, Lim DT, Soo KC, Tan P.

Genes Chromosomes Cancer. 2008 Apr;47(4):353-62. doi: 10.1002/gcc.20539.

PMID:
18196592
[PubMed - indexed for MEDLINE]
9.

KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.

Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, Yu D, Myers JN, Kupferman ME.

Oncogene. 2011 Jul 14;30(28):3163-73. doi: 10.1038/onc.2011.39. Epub 2011 Mar 7.

PMID:
21383688
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma.

Liu W, Lu M, Liu B, Huang Y, Wang K.

Cancer Lett. 2012 Dec 29;326(1):41-51. doi: 10.1016/j.canlet.2012.07.015. Epub 2012 Jul 20.

PMID:
22820160
[PubMed - indexed for MEDLINE]
11.

Role of anoctamins in cancer and apoptosis.

Wanitchakool P, Wolf L, Koehl GE, Sirianant L, Schreiber R, Kulkarni S, Duvvuri U, Kunzelmann K.

Philos Trans R Soc Lond B Biol Sci. 2014 Feb 3;369(1638):20130096. doi: 10.1098/rstb.2013.0096. Print 2014 Mar 19.

PMID:
24493744
[PubMed - in process]
12.

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.

Shimizu S, Tsukada J, Sugimoto T, Kikkawa N, Sasaki K, Chazono H, Hanazawa T, Okamoto Y, Seki N.

Int J Cancer. 2008 Oct 15;123(8):1816-23. doi: 10.1002/ijc.23710.

PMID:
18661521
[PubMed - indexed for MEDLINE]
13.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

PMID:
11683369
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM.

Oncogene. 2009 Jan 22;28(3):431-44. doi: 10.1038/onc.2008.389. Epub 2008 Oct 20.

PMID:
18931703
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2013 May;139(5):727-37. doi: 10.1007/s00432-013-1375-7. Epub 2013 Jan 25.

PMID:
23354841
[PubMed - indexed for MEDLINE]
16.

Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.

Freier K, Hofele C, Knoepfle K, Gross M, Devens F, Dyckhoff G, Plinkert P, Lichter P, Herold-Mende C.

J Oral Pathol Med. 2010 May;39(5):382-9. doi: 10.1111/j.1600-0714.2009.00864.x. Epub 2010 Feb 8.

PMID:
20149059
[PubMed - indexed for MEDLINE]
17.

Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.

Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, Kinnunen I, Ventelä S.

Oral Oncol. 2011 Jun;47(6):510-6. doi: 10.1016/j.oraloncology.2011.03.026. Epub 2011 Apr 22.

PMID:
21514878
[PubMed - indexed for MEDLINE]
18.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
[PubMed - indexed for MEDLINE]
19.

Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.

Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.

J Pathol. 2008 Mar;214(4):489-97. doi: 10.1002/path.2306.

PMID:
18213732
[PubMed - indexed for MEDLINE]
20.

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.

Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2005 Apr 15;11(8):2937-46.

PMID:
15837745
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk